Literature DB >> 9199974

Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).

A Godkin1, T Friede, M Davenport, S Stevanovic, A Willis, D Jewell, A Hill, H G Rammensee.   

Abstract

HLA-DQ8 (A1*0301, B1*0302) and -DQ2 (A1*0501, B1*0201) are both associated with diseases such as insulin-dependent diabetes mellitus and coeliac disease. We used the technique of pool sequencing to look at the requirements of peptides binding to HLA-DQ8, and combined these data with naturally sequenced ligands and in vitro binding assays to describe a novel motif for HLA-DQ8. The motif, which has the same basic format as many HLA-DR molecules, consists of four or five anchor regions, in the positions from the N-terminus of the binding core of n, n + 3, n + 5/6 and n + 8, i.e. P1, P4, P6/7 and P9. P1 and P9 require negative or polar residues, with mainly aliphatic residues at P4 and P6/7. The features of the HLA-DQ8 motif were then compared to a pool sequence of peptides eluted from HLA-DQ2. A consensus motif for the binding of a common peptide which may be involved in disease pathogenesis is described. Neither of the disease-associated alleles HLA-DQ2 and -DQ8 have Asp at position 57 of the beta-chain. This Asp, if present, may form a salt bridge with an Arg at position 79 of the alpha-chain and so alter the binding specificity of P9. HLA-DQ2 and -DQ8 both appear to prefer negatively charged amino acids at P9. In contrast, HLA-DQ7 (A1*0301, B1*0301), which is not associated with diabetes, has Asp at beta 57, allowing positively charged amino acids at P9. This analysis of the sequence features of DQ-binding peptides suggests molecular characteristics which may be useful to predict epitopes involved in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199974     DOI: 10.1093/intimm/9.6.905

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  22 in total

1.  Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life.

Authors:  G K Papadopoulos; C Wijmenga; F Koning
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

2.  Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.

Authors:  Menno van Lummel; Peter A van Veelen; Arnaud Zaldumbide; Arnoud de Ru; George M C Janssen; Antonis K Moustakas; George K Papadopoulos; Jan W Drijfhout; Bart O Roep; Frits Koning
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

3.  Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.

Authors:  Anish Suri; James J Walters; Michael L Gross; Emil R Unanue
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 4.  Gluten: a two-edged sword. Immunopathogenesis of celiac disease.

Authors:  Frits Koning; Luud Gilissen; Cisca Wijmenga
Journal:  Springer Semin Immunopathol       Date:  2005-08-10

5.  The production and crystallization of the human leukocyte antigen class II molecules HLA-DQ2 and HLA-DQ8 complexed with deamidated gliadin peptides implicated in coeliac disease.

Authors:  Kate N Henderson; Hugh H Reid; Natalie A Borg; Sophie E Broughton; Trevor Huyton; Robert P Anderson; James McCluskey; Jamie Rossjohn
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-21

Review 6.  Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease.

Authors:  P C Dubois; D A van Heel
Journal:  Clin Exp Immunol       Date:  2008-08       Impact factor: 4.330

7.  Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4+ T Cells in Patients With Type 1 Diabetes.

Authors:  Meghan L Marre; John W McGinty; I-Ting Chow; Megan E DeNicola; Noah W Beck; Sally C Kent; Alvin C Powers; Rita Bottino; David M Harlan; Carla J Greenbaum; William W Kwok; Jon D Piganelli; Eddie A James
Journal:  Diabetes       Date:  2018-04-13       Impact factor: 9.461

8.  HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.

Authors:  Stig Tollefsen; Helene Arentz-Hansen; Burkhard Fleckenstein; Oyvind Molberg; Melinda Ráki; William W Kwok; Günther Jung; Knut E A Lundin; Ludvig M Sollid
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

Review 9.  The roles of MHC class II genes and post-translational modification in celiac disease.

Authors:  Ludvig M Sollid
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

10.  The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.

Authors:  Siri Dørum; Magnus Ø Arntzen; Shuo-Wang Qiao; Anders Holm; Christian J Koehler; Bernd Thiede; Ludvig M Sollid; Burkhard Fleckenstein
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.